Total Funding
1
1
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
316924
Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.
Lex H.T. Van der Ploeg: Chief Scientific OfficerPast Role: Retrotope, Interim Chairman BOD- Fred T. Fiedorek: Chief Medical OfficerPast Role: Intarcia Therapeutics, Chief Medical Officer & Head of Global Regulatory Affairs
About the Company
Motus Therapeutics is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.
Women Founded
